Skip to main content
Home
Browse by Topic
Issues
Online First
Latest Issue
Issue Archive
Special Issues
PSS Guide
Index
Introduction
Special Series
OFS Summit
Conference Correspondent
SABCS 2023 - HER2+ MBC
SABCS 2023 - HR+/HER2- MBC
ESMO 2023 - Small Cell Lung Cancer
ASCO 2023 - Breast Cancer
Monthly Minutes
Gastrointestinal Cancer
Lung Cancer
Multiple Myeloma
Women's Health
Multimedia
All Videos
Interview with the Innovators
Rapid Reactions
Webinars
Subscribe
Home
Browse by Topic
Issues
Online First
Latest Issue
Issue Archive
Special Issues
PSS Guide
Index
Introduction
Special Series
OFS Summit
Conference Correspondent
SABCS 2023 - HER2+ MBC
SABCS 2023 - HR+/HER2- MBC
ESMO 2023 - Small Cell Lung Cancer
ASCO 2023 - Breast Cancer
Monthly Minutes
Gastrointestinal Cancer
Lung Cancer
Multiple Myeloma
Women's Health
Multimedia
All Videos
Interview with the Innovators
Rapid Reactions
Webinars
Subscribe
January 2016, Vol 6, No 1
Updates on Recent Cancer Drugs Approved by the FDA
FDA Approvals, News & Updates
January 2016, Vol 6, No 1
Read More ›
Keytruda (Pembrolizumab) First PD-1 Inhibitor Approved for the Treatment of Patients with Metastatic Non–Small-Cell Lung Cancer Expressing PD-L1
By
Lisa A. Raedler, PhD, RPh
Drug Updates
January 2016, Vol 6, No 1
Read More ›
Medications Used for the Treatment of Pancreatic Cancer Associated with ICD-10 Codes
By
Kristin A. Esposito, CPhT
Cancer Drug Coding
,
ICD Codes
,
Reimbursement
,
Drug Coding
January 2016, Vol 6, No 1
The following sections will assist healthcare professionals and payers by providing appropriate coding and billing information associated with the treatment of pancreatic cancer.
Read More ›
Page 2 of 2
1
2